Loading…

Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia

Background Stroke is a devastating complication of sickle cell anemia (SCA) and can be predicted through abnormally high cerebral blood flow velocity using transcranial Doppler Ultrasonography (TCD). The evidence on the role of alpha‐thalassemia and glucose‐6‐phosphate dehydrogenase (G6PD) deficienc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical laboratory analysis 2021-06, Vol.35 (6), p.e23802-n/a
Main Authors: Ojewunmi, Oyesola Oyewole, Adeyemo, Titilope Adenike, Oyetunji, Ajoke Idayat, Benn, Yewande, Ekpo, Mfoniso Godwin, Iwalokun, Bamidele Abiodun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4482-42ba5abf52c4fb8c40273dbbbd099f4d31080640321457f713a24f1808b815d43
cites cdi_FETCH-LOGICAL-c4482-42ba5abf52c4fb8c40273dbbbd099f4d31080640321457f713a24f1808b815d43
container_end_page n/a
container_issue 6
container_start_page e23802
container_title Journal of clinical laboratory analysis
container_volume 35
creator Ojewunmi, Oyesola Oyewole
Adeyemo, Titilope Adenike
Oyetunji, Ajoke Idayat
Benn, Yewande
Ekpo, Mfoniso Godwin
Iwalokun, Bamidele Abiodun
description Background Stroke is a devastating complication of sickle cell anemia (SCA) and can be predicted through abnormally high cerebral blood flow velocity using transcranial Doppler Ultrasonography (TCD). The evidence on the role of alpha‐thalassemia and glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in the development of stroke in children with SCA is conflicting. Thus, this study investigated the association of alpha‐thalassemia and G6PD(A−) variant with abnormal TCD velocities among Nigerian children with SCA. Methods One hundred and forty‐one children with SCA were recruited: 72 children presented with normal TCD (defined as the time‐averaged mean of the maximum velocity:  A and 376A > G) were genotyped using restriction fragment length polymorphism—polymerase chain reaction. Results The frequency of α‐thalassemia trait in the children with normal TCD was higher than those with abnormal TCD: 38/72 (52.8%) [α‐/ α α: 41.7%, α ‐/ α ‐: 11.1%] versus 21/69 (30.4%) [α‐/ α α: 27.5%, α ‐/ α ‐: 2.9%], and the odds of abnormal TCD were reduced in the presence of the α‐thalassemia trait [Odds Ratio: 0.39, 95% confidence interval: 0.20–0.78, p = 0.007]. However, the frequencies of G6PDA− variant in children with abnormal and normal TCD were similar (11.6% vs. 15.3%, p = 0.522). Conclusion Our study reveals the protective role of α‐thalassemia against the risk of abnormal TCD in Nigerian children with SCA. We investigated the association of alpha‐thalassemia deletion and G6PD deficiency [G6PDA‐] with stroke risk as stratified by TCD velocity status among Nigerian children with sickle cell anemia. Our results show that absence of α‐thalassemia increased risk of abnormal TCD and remains an independent predictor of abnormal TCD alongside lower hemoglobin oxygen saturation.
doi_str_mv 10.1002/jcla.23802
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8183942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2521496465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4482-42ba5abf52c4fb8c40273dbbbd099f4d31080640321457f713a24f1808b815d43</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhS0EotPChgdAltigSin-S-JskEZTKKARsIC15Tj2xIPHDnZClR2PwJPwUDwJHlIqYMHCtuT7-dxz5AvAI4wuMELk2V45eUEoR-QOWGHU8IJwUt4FK8R5XXCE6Qk4TWmPEOINru6DE0obysuGr8D3dUpBWTna4GEwULqhlz--fht76WRK-mAllL6DV25SIelcqfJ634eUuVHDS93PXQw77WXSsNPGKqu9muG1HXs4RumTypuVDl6GYXA6wsnl6xR82EU59DO0Hr61Ox2t9FD11nVR--V5suqT01Bp57KJo5cH4J6RLumHN-cZ-PjyxYfNq2L77ur1Zr0tFGOcFIy0spStKYlipuWKIVLTrm3bDjWNYR3FiKOKIUowK2tTYyoJM5gj3nJcdoyegeeL7jC1B90p7bNnJ4ZoDzLOIkgr_q5424td-CI45rRhJAs8vRGI4fOk0ygONh2D5BxhSoKUuXVTsarM6JN_0H2Yos_xMkXrqqZVWWfqfKFUDClFbW7NYCSOYyCOYyB-jUGGH_9p_xb9_e8ZwAtwbZ2e_yMl3my260X0J4udxLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2537673657</pqid></control><display><type>article</type><title>Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia</title><source>Publicly Available Content Database</source><source>Wiley Open Access Journals</source><source>PubMed Central</source><creator>Ojewunmi, Oyesola Oyewole ; Adeyemo, Titilope Adenike ; Oyetunji, Ajoke Idayat ; Benn, Yewande ; Ekpo, Mfoniso Godwin ; Iwalokun, Bamidele Abiodun</creator><creatorcontrib>Ojewunmi, Oyesola Oyewole ; Adeyemo, Titilope Adenike ; Oyetunji, Ajoke Idayat ; Benn, Yewande ; Ekpo, Mfoniso Godwin ; Iwalokun, Bamidele Abiodun</creatorcontrib><description>Background Stroke is a devastating complication of sickle cell anemia (SCA) and can be predicted through abnormally high cerebral blood flow velocity using transcranial Doppler Ultrasonography (TCD). The evidence on the role of alpha‐thalassemia and glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in the development of stroke in children with SCA is conflicting. Thus, this study investigated the association of alpha‐thalassemia and G6PD(A−) variant with abnormal TCD velocities among Nigerian children with SCA. Methods One hundred and forty‐one children with SCA were recruited: 72 children presented with normal TCD (defined as the time‐averaged mean of the maximum velocity: &lt; 170 cm/s) and 69 children with abnormal TCD (TAMMV ≥ 200 cm/s). Alpha‐thalassemia (the α‐3.7 globin gene deletion) was determined by multiplex gap‐PCR, while G6PD polymorphisms (202G &gt; A and 376A &gt; G) were genotyped using restriction fragment length polymorphism—polymerase chain reaction. Results The frequency of α‐thalassemia trait in the children with normal TCD was higher than those with abnormal TCD: 38/72 (52.8%) [α‐/ α α: 41.7%, α ‐/ α ‐: 11.1%] versus 21/69 (30.4%) [α‐/ α α: 27.5%, α ‐/ α ‐: 2.9%], and the odds of abnormal TCD were reduced in the presence of the α‐thalassemia trait [Odds Ratio: 0.39, 95% confidence interval: 0.20–0.78, p = 0.007]. However, the frequencies of G6PDA− variant in children with abnormal and normal TCD were similar (11.6% vs. 15.3%, p = 0.522). Conclusion Our study reveals the protective role of α‐thalassemia against the risk of abnormal TCD in Nigerian children with SCA. We investigated the association of alpha‐thalassemia deletion and G6PD deficiency [G6PDA‐] with stroke risk as stratified by TCD velocity status among Nigerian children with sickle cell anemia. Our results show that absence of α‐thalassemia increased risk of abnormal TCD and remains an independent predictor of abnormal TCD alongside lower hemoglobin oxygen saturation.</description><identifier>ISSN: 0887-8013</identifier><identifier>EISSN: 1098-2825</identifier><identifier>DOI: 10.1002/jcla.23802</identifier><identifier>PMID: 33938598</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>alpha‐thalassemia ; Anemia ; Blood diseases ; Blood flow ; Blood transfusions ; Cerebral blood flow ; Children ; Dehydrogenases ; Doppler effect ; Gene deletion ; Glucose ; Glucosephosphate dehydrogenase ; glucose‐6‐phosphate dehydrogenase deficiency ; Hemoglobin ; Laboratories ; Polymerase chain reaction ; Restriction fragment length polymorphism ; Sickle cell anemia ; Sickle cell disease ; Stroke ; Thalassemia ; transcranial Doppler ultrasonography ; Ultrasound ; Velocity</subject><ispartof>Journal of clinical laboratory analysis, 2021-06, Vol.35 (6), p.e23802-n/a</ispartof><rights>2021 The Authors. published by Wiley Periodicals LLC</rights><rights>2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4482-42ba5abf52c4fb8c40273dbbbd099f4d31080640321457f713a24f1808b815d43</citedby><cites>FETCH-LOGICAL-c4482-42ba5abf52c4fb8c40273dbbbd099f4d31080640321457f713a24f1808b815d43</cites><orcidid>0000-0003-2774-650X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2537673657/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2537673657?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,11549,25740,27911,27912,36999,37000,44577,46039,46463,53778,53780,74881</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33938598$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ojewunmi, Oyesola Oyewole</creatorcontrib><creatorcontrib>Adeyemo, Titilope Adenike</creatorcontrib><creatorcontrib>Oyetunji, Ajoke Idayat</creatorcontrib><creatorcontrib>Benn, Yewande</creatorcontrib><creatorcontrib>Ekpo, Mfoniso Godwin</creatorcontrib><creatorcontrib>Iwalokun, Bamidele Abiodun</creatorcontrib><title>Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia</title><title>Journal of clinical laboratory analysis</title><addtitle>J Clin Lab Anal</addtitle><description>Background Stroke is a devastating complication of sickle cell anemia (SCA) and can be predicted through abnormally high cerebral blood flow velocity using transcranial Doppler Ultrasonography (TCD). The evidence on the role of alpha‐thalassemia and glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in the development of stroke in children with SCA is conflicting. Thus, this study investigated the association of alpha‐thalassemia and G6PD(A−) variant with abnormal TCD velocities among Nigerian children with SCA. Methods One hundred and forty‐one children with SCA were recruited: 72 children presented with normal TCD (defined as the time‐averaged mean of the maximum velocity: &lt; 170 cm/s) and 69 children with abnormal TCD (TAMMV ≥ 200 cm/s). Alpha‐thalassemia (the α‐3.7 globin gene deletion) was determined by multiplex gap‐PCR, while G6PD polymorphisms (202G &gt; A and 376A &gt; G) were genotyped using restriction fragment length polymorphism—polymerase chain reaction. Results The frequency of α‐thalassemia trait in the children with normal TCD was higher than those with abnormal TCD: 38/72 (52.8%) [α‐/ α α: 41.7%, α ‐/ α ‐: 11.1%] versus 21/69 (30.4%) [α‐/ α α: 27.5%, α ‐/ α ‐: 2.9%], and the odds of abnormal TCD were reduced in the presence of the α‐thalassemia trait [Odds Ratio: 0.39, 95% confidence interval: 0.20–0.78, p = 0.007]. However, the frequencies of G6PDA− variant in children with abnormal and normal TCD were similar (11.6% vs. 15.3%, p = 0.522). Conclusion Our study reveals the protective role of α‐thalassemia against the risk of abnormal TCD in Nigerian children with SCA. We investigated the association of alpha‐thalassemia deletion and G6PD deficiency [G6PDA‐] with stroke risk as stratified by TCD velocity status among Nigerian children with sickle cell anemia. Our results show that absence of α‐thalassemia increased risk of abnormal TCD and remains an independent predictor of abnormal TCD alongside lower hemoglobin oxygen saturation.</description><subject>alpha‐thalassemia</subject><subject>Anemia</subject><subject>Blood diseases</subject><subject>Blood flow</subject><subject>Blood transfusions</subject><subject>Cerebral blood flow</subject><subject>Children</subject><subject>Dehydrogenases</subject><subject>Doppler effect</subject><subject>Gene deletion</subject><subject>Glucose</subject><subject>Glucosephosphate dehydrogenase</subject><subject>glucose‐6‐phosphate dehydrogenase deficiency</subject><subject>Hemoglobin</subject><subject>Laboratories</subject><subject>Polymerase chain reaction</subject><subject>Restriction fragment length polymorphism</subject><subject>Sickle cell anemia</subject><subject>Sickle cell disease</subject><subject>Stroke</subject><subject>Thalassemia</subject><subject>transcranial Doppler ultrasonography</subject><subject>Ultrasound</subject><subject>Velocity</subject><issn>0887-8013</issn><issn>1098-2825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp9ks1u1DAUhS0EotPChgdAltigSin-S-JskEZTKKARsIC15Tj2xIPHDnZClR2PwJPwUDwJHlIqYMHCtuT7-dxz5AvAI4wuMELk2V45eUEoR-QOWGHU8IJwUt4FK8R5XXCE6Qk4TWmPEOINru6DE0obysuGr8D3dUpBWTna4GEwULqhlz--fht76WRK-mAllL6DV25SIelcqfJ634eUuVHDS93PXQw77WXSsNPGKqu9muG1HXs4RumTypuVDl6GYXA6wsnl6xR82EU59DO0Hr61Ox2t9FD11nVR--V5suqT01Bp57KJo5cH4J6RLumHN-cZ-PjyxYfNq2L77ur1Zr0tFGOcFIy0spStKYlipuWKIVLTrm3bDjWNYR3FiKOKIUowK2tTYyoJM5gj3nJcdoyegeeL7jC1B90p7bNnJ4ZoDzLOIkgr_q5424td-CI45rRhJAs8vRGI4fOk0ygONh2D5BxhSoKUuXVTsarM6JN_0H2Yos_xMkXrqqZVWWfqfKFUDClFbW7NYCSOYyCOYyB-jUGGH_9p_xb9_e8ZwAtwbZ2e_yMl3my260X0J4udxLg</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Ojewunmi, Oyesola Oyewole</creator><creator>Adeyemo, Titilope Adenike</creator><creator>Oyetunji, Ajoke Idayat</creator><creator>Benn, Yewande</creator><creator>Ekpo, Mfoniso Godwin</creator><creator>Iwalokun, Bamidele Abiodun</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2774-650X</orcidid></search><sort><creationdate>202106</creationdate><title>Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia</title><author>Ojewunmi, Oyesola Oyewole ; Adeyemo, Titilope Adenike ; Oyetunji, Ajoke Idayat ; Benn, Yewande ; Ekpo, Mfoniso Godwin ; Iwalokun, Bamidele Abiodun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4482-42ba5abf52c4fb8c40273dbbbd099f4d31080640321457f713a24f1808b815d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>alpha‐thalassemia</topic><topic>Anemia</topic><topic>Blood diseases</topic><topic>Blood flow</topic><topic>Blood transfusions</topic><topic>Cerebral blood flow</topic><topic>Children</topic><topic>Dehydrogenases</topic><topic>Doppler effect</topic><topic>Gene deletion</topic><topic>Glucose</topic><topic>Glucosephosphate dehydrogenase</topic><topic>glucose‐6‐phosphate dehydrogenase deficiency</topic><topic>Hemoglobin</topic><topic>Laboratories</topic><topic>Polymerase chain reaction</topic><topic>Restriction fragment length polymorphism</topic><topic>Sickle cell anemia</topic><topic>Sickle cell disease</topic><topic>Stroke</topic><topic>Thalassemia</topic><topic>transcranial Doppler ultrasonography</topic><topic>Ultrasound</topic><topic>Velocity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ojewunmi, Oyesola Oyewole</creatorcontrib><creatorcontrib>Adeyemo, Titilope Adenike</creatorcontrib><creatorcontrib>Oyetunji, Ajoke Idayat</creatorcontrib><creatorcontrib>Benn, Yewande</creatorcontrib><creatorcontrib>Ekpo, Mfoniso Godwin</creatorcontrib><creatorcontrib>Iwalokun, Bamidele Abiodun</creatorcontrib><collection>Wiley Open Access Journals</collection><collection>Wiley Online Library Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical laboratory analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ojewunmi, Oyesola Oyewole</au><au>Adeyemo, Titilope Adenike</au><au>Oyetunji, Ajoke Idayat</au><au>Benn, Yewande</au><au>Ekpo, Mfoniso Godwin</au><au>Iwalokun, Bamidele Abiodun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia</atitle><jtitle>Journal of clinical laboratory analysis</jtitle><addtitle>J Clin Lab Anal</addtitle><date>2021-06</date><risdate>2021</risdate><volume>35</volume><issue>6</issue><spage>e23802</spage><epage>n/a</epage><pages>e23802-n/a</pages><issn>0887-8013</issn><eissn>1098-2825</eissn><abstract>Background Stroke is a devastating complication of sickle cell anemia (SCA) and can be predicted through abnormally high cerebral blood flow velocity using transcranial Doppler Ultrasonography (TCD). The evidence on the role of alpha‐thalassemia and glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in the development of stroke in children with SCA is conflicting. Thus, this study investigated the association of alpha‐thalassemia and G6PD(A−) variant with abnormal TCD velocities among Nigerian children with SCA. Methods One hundred and forty‐one children with SCA were recruited: 72 children presented with normal TCD (defined as the time‐averaged mean of the maximum velocity: &lt; 170 cm/s) and 69 children with abnormal TCD (TAMMV ≥ 200 cm/s). Alpha‐thalassemia (the α‐3.7 globin gene deletion) was determined by multiplex gap‐PCR, while G6PD polymorphisms (202G &gt; A and 376A &gt; G) were genotyped using restriction fragment length polymorphism—polymerase chain reaction. Results The frequency of α‐thalassemia trait in the children with normal TCD was higher than those with abnormal TCD: 38/72 (52.8%) [α‐/ α α: 41.7%, α ‐/ α ‐: 11.1%] versus 21/69 (30.4%) [α‐/ α α: 27.5%, α ‐/ α ‐: 2.9%], and the odds of abnormal TCD were reduced in the presence of the α‐thalassemia trait [Odds Ratio: 0.39, 95% confidence interval: 0.20–0.78, p = 0.007]. However, the frequencies of G6PDA− variant in children with abnormal and normal TCD were similar (11.6% vs. 15.3%, p = 0.522). Conclusion Our study reveals the protective role of α‐thalassemia against the risk of abnormal TCD in Nigerian children with SCA. We investigated the association of alpha‐thalassemia deletion and G6PD deficiency [G6PDA‐] with stroke risk as stratified by TCD velocity status among Nigerian children with sickle cell anemia. Our results show that absence of α‐thalassemia increased risk of abnormal TCD and remains an independent predictor of abnormal TCD alongside lower hemoglobin oxygen saturation.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33938598</pmid><doi>10.1002/jcla.23802</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-2774-650X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0887-8013
ispartof Journal of clinical laboratory analysis, 2021-06, Vol.35 (6), p.e23802-n/a
issn 0887-8013
1098-2825
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8183942
source Publicly Available Content Database; Wiley Open Access Journals; PubMed Central
subjects alpha‐thalassemia
Anemia
Blood diseases
Blood flow
Blood transfusions
Cerebral blood flow
Children
Dehydrogenases
Doppler effect
Gene deletion
Glucose
Glucosephosphate dehydrogenase
glucose‐6‐phosphate dehydrogenase deficiency
Hemoglobin
Laboratories
Polymerase chain reaction
Restriction fragment length polymorphism
Sickle cell anemia
Sickle cell disease
Stroke
Thalassemia
transcranial Doppler ultrasonography
Ultrasound
Velocity
title Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T23%3A47%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20alpha%E2%80%90thalassemia%20and%20Glucose%E2%80%906%E2%80%90Phosphate%20Dehydrogenase%20deficiency%20with%20transcranial%20Doppler%20ultrasonography%20in%20Nigerian%20children%20with%20sickle%20cell%20anemia&rft.jtitle=Journal%20of%20clinical%20laboratory%20analysis&rft.au=Ojewunmi,%20Oyesola%20Oyewole&rft.date=2021-06&rft.volume=35&rft.issue=6&rft.spage=e23802&rft.epage=n/a&rft.pages=e23802-n/a&rft.issn=0887-8013&rft.eissn=1098-2825&rft_id=info:doi/10.1002/jcla.23802&rft_dat=%3Cproquest_pubme%3E2521496465%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4482-42ba5abf52c4fb8c40273dbbbd099f4d31080640321457f713a24f1808b815d43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2537673657&rft_id=info:pmid/33938598&rfr_iscdi=true